scispace - formally typeset
Open AccessJournal ArticleDOI

Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies

Jakob Regberg, +2 more
- 12 Sep 2012 - 
- Vol. 5, Iss: 9, pp 991-1007
TLDR
This review is focused on the cancer applications of cell penetrating peptides as delivery systems; different aspects of drug loading, cargoes and delivery are discussed together with methods for targeted delivery, activatable cell-penetrating peptides and transducible agents coupled to cell-Penetrating Peptide based delivery.
Abstract
Cell-penetrating peptides provide a highly promising strategy for intracellular drug delivery. One relevant clinical application of cell-penetrating peptides is cancer therapeutics. Peptide based delivery could increase the uptake of drugs in tumor cells and thereby increase the efficacy of the treatment, either of conventional small molecular drugs or oligonucleotide based therapeutics. This review is focused on the cancer applications of cell penetrating peptides as delivery systems; different aspects of drug loading, cargoes and delivery are discussed together with methods for targeted delivery, activatable cell-penetrating peptides and transducible agents coupled to cell-penetrating peptides.

read more

Citations
More filters
Journal ArticleDOI

Cell-Penetrating Peptides: From Basic Research to Clinics

TL;DR: In this article, cell-penetrating peptides (CPPs) have been used to increase medicament concentrations in areas that are difficult to access, which can transport into the cell a wide variety of biologically active conjugates.
Journal ArticleDOI

Evaluation of the use of therapeutic peptides for cancer treatment

TL;DR: In this review, strategies used to overcome peptide limitations and to enhance their therapeutic effect will be compared and the use of short cell permeable peptides that interfere and inhibit protein-protein interactions will be evaluated.
Journal ArticleDOI

Cell penetrating peptides: A concise review with emphasis on biomedical applications.

TL;DR: Owing to the ability of CPPs to transport across cellular membrane, they can employ as an appropriate carrier for various cargos include nucleic acid, proteins, SiRNA, therapeutic agents, nanoparticles and so on.
Journal ArticleDOI

Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.

TL;DR: This review focuses on peptides as carriers and targeting moieties in drug‐peptide covalent conjugates and summarizes the most recent literature examples where CPPs on their own or CPP's together with TTPs have been conjugated to anticancer drugs such as Doxorubicin, Methotrexate, Paclitaxel, Chlorambucil etc.
Patent

Modified nucleosides, nucleotides, and nucleic acids, and uses thereof

TL;DR: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them as discussed by the authors, as well as a detailed discussion of their properties.
References
More filters
Journal ArticleDOI

A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus

TL;DR: The main determinants required for Tat translocation within this sequence are delineated by synthesizing several peptides covering the Tat domain from residues 37 to 60 and the domain extending from amino acid 37 to 47, which corresponds to the α-helix structure, is not required for cellular uptake and for nuclear translocation.
Journal ArticleDOI

The third helix of the Antennapedia homeodomain translocates through biological membranes

TL;DR: It is reported here that a polypeptide of 16 amino acids in length corresponding to the third helix of the homeodomain deleted of its N-terminal glutamate is still capable of translocating through the membrane, suggesting an energy-independent mechanism of translocation not involving classical endocytosis.
Journal ArticleDOI

Matrix metalloproteinases and tumor metastasis

TL;DR: The major pieces of evidence that are most compelling and clearly determine the role and involvement of MMPs in the metastatic cascade are provided by molecular genetic studies employing knock-out or transgenic animals and tumor cell lines, modified to overexpress or downregulate a specific MMP.
PatentDOI

Cell penetrating peptides

TL;DR: In this article, the present invention discloses cell penetrating peptides and conjugates of a cell-penetrating peptide and a cargo molecule, as well as their conjugations.
Journal ArticleDOI

Transvascular delivery of small interfering RNA to the central nervous system

TL;DR: RVG-9R provides a safe and noninvasive approach for the delivery of siRNA and potentially other therapeutic molecules across the blood–brain barrier and afforded robust protection against fatal viral encephalitis in mice.
Related Papers (5)